Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment

Area of Science:

• Neurology
• Pharmacology
• Clinical Research

Background:

• Simultaneous treatment with multiple antiepileptic drugs (AEDs) in epilepsy patients may increase adverse effects compared to monotherapy.
• Quantitative data supporting this claim is often lacking.
• This study addresses the need for comparative analysis of adverse effects in epilepsy treatment.

Purpose of the Study:

• To quantitatively compare the prevalence of adverse effects between antiepileptic drug monotherapy and polytherapy.
• To investigate the relationship between drug dosage standardization and adverse event occurrence in epilepsy patients.

Main Methods:

• A cohort of epilepsy outpatients from The Netherlands was recruited.
• Antiepileptic drug doses were standardized using the prescribed daily dose to defined daily dose (PDD/DDD) ratio.
• Adverse effect severity was assessed using the Neurotoxicity Index and Systemic Toxicity Index.

Main Results:

• The prevalence of neurological adverse effects in patients with similar PDD/DDD ratios was comparable between monotherapy (50-80%) and polytherapy (50-82%) groups.
• No statistically significant difference in neurological adverse effects was observed between monotherapy and polytherapy groups.
• The study analyzed 161 monotherapy patients and 262 polytherapy patients.

Conclusions:

• The study suggests that polytherapy for epilepsy does not lead to a significantly higher prevalence of neurological adverse effects compared to monotherapy when adjusted for dosage.
• Further research may be needed to explore other types of adverse effects or specific drug combinations.